🇺🇸 FDA
Patent

US 11040125

Neurotrophic factor carrier, method for producing the same, and method for regenerating a nerve using the same

granted A61KA61K31/727A61K38/185

Quick answer

US patent 11040125 (Neurotrophic factor carrier, method for producing the same, and method for regenerating a nerve using the same) held by Wiregene Co., Ltd. expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Wiregene Co., Ltd.
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/727, A61K38/185